Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


OLIENA
Language recovery after stroke
App | Video | PDF (278 pp) | Web

  Epilepsy

  Free Subscription


Articles published in Eur J Clin Pharmacol

Retrieve available abstracts of 10 articles:
HTML format
Text format



Single Articles


    January 2019
  1. SHI L, Zhu M, Li H, Wen Z, et al
    SCN1A and SCN2A polymorphisms are associated with response to valproic acid in Chinese epilepsy patients.
    Eur J Clin Pharmacol. 2019 Jan 28. pii: 10.1007/s00228-019-02633.
    PubMed     Text format     Abstract available


  2. MANOHARAN A, Kumar AS, Sreedevi A, Sathishkannan AD, et al
    HLA-B*5701 and HLA-B*5801 in an Indian patient with anti-epileptics induced cutaneous adverse drug reactions.
    Eur J Clin Pharmacol. 2019 Jan 4. pii: 10.1007/s00228-018-02618.
    PubMed     Text format    


    November 2018
  3. LIN WW, Li XW, Jiao Z, Zhang J, et al
    Population pharmacokinetics of oxcarbazepine active metabolite in Chinese paediatric epilepsy patients and its application in individualised dosage regimens.
    Eur J Clin Pharmacol. 2018 Nov 19. pii: 10.1007/s00228-018-2600.
    PubMed     Text format     Abstract available


    April 2018
  4. MEI S, Feng W, Zhu L, Li X, et al
    Effect of CYP2C19, UGT1A8, and UGT2B7 on valproic acid clearance in children with epilepsy: a population pharmacokinetic model.
    Eur J Clin Pharmacol. 2018 Apr 17. pii: 10.1007/s00228-018-2440.
    PubMed     Text format     Abstract available


  5. WANG P, Lin XQ, Cai WK, Xu GL, et al
    Effect of UGT2B7 genotypes on plasma concentration of valproic acid: a meta-analysis.
    Eur J Clin Pharmacol. 2018;74:433-442.
    PubMed     Text format     Abstract available


    March 2018
  6. RODRIGUES C, Chhun S, Chiron C, Dulac O, et al
    A population pharmacokinetic model taking into account protein binding for the sustained-release granule formulation of valproic acid in children with epilepsy.
    Eur J Clin Pharmacol. 2018 Mar 21. pii: 10.1007/s00228-018-2444.
    PubMed     Text format     Abstract available


    February 2018
  7. KHELOUFI F, Default A, Perrouty B, Blin O, et al
    Perampanel-associated self-harm ideation after dosage increase.
    Eur J Clin Pharmacol. 2018;74:243-244.
    PubMed     Text format    


    January 2018
  8. MORATH B, Green K, Zaradzki M, Heid J, et al
    Subtherapeutic valproic acid plasma concentrations under concomitant dipyrone therapy in an epilepsy patient-a case report.
    Eur J Clin Pharmacol. 2018 Jan 23. pii: 10.1007/s00228-018-2417.
    PubMed     Text format    


  9. XU S, Liu L, Chen Y, Liu M, et al
    Population pharmacokinetics of lamotrigine co-administered with valproic acid in Chinese epileptic children using nonlinear mixed effects modeling.
    Eur J Clin Pharmacol. 2018 Jan 16. pii: 10.1007/s00228-018-2414.
    PubMed     Text format     Abstract available


    April 2017
  10. BAFTIU A, Landmark CJ, Rusten IR, Feet SA, et al
    Erratum to: Changes in utilisation of antiepileptic drugs in epilepsy and non-epilepsy disorders-A pharmacoepidemiological study and clinical implications.
    Eur J Clin Pharmacol. 2017 Apr 7. doi: 10.1007/s00228-017-2252.
    PubMed     Text format    


Thank you for your interest in scientific medicine.


AMEDEO Epilepsy is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: